COVID-19 Vaccine Acceptance and Hesitancy Among Patients with Cancer: a Systematic Review and Meta-analysis

Overview

Journal Public Health

Publisher Elsevier

Specialty Public Health

Date 2022 Oct 16

PMID 36244261

Authors

K I P Prabani

I Weerasekara

H D W T Damayanthi

Affiliations

Soon will be listed here.

Abstract

Objectives: Patients with cancer are more vulnerable to COVID-19 morbidity and morbidity than the general population and have been prioritised in COVID-19 vaccination programmes. This study aims to investigate COVID-19 vaccine acceptance and hesitancy among patients with cancer.

Study Design: This was a systematic review and meta-analysis.

Methods: PubMed, ScienceDirect and the Cochrane COVID-19 study registry were searched in addition to secondary literature using a predefined search method. Two authors independently performed the study identification, screening and eligibility assessment. This study followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses 2020 guidelines and Joanna Brides' Institute quality appraisal tools.

Results: A total of 29 studies and reports were selected for the final review. The pooled prevalence of vaccine acceptance was 59% (95% confidence interval 52-67%, I: 99%). Concerns about vaccine-related side-effects, uncertainty about vaccine efficacy and safety, ongoing active anticancer therapies and scepticism about rapid vaccine development were the leading causes for vaccine hesitancy. Female gender and undergoing active anticancer treatments were significant factors associated with COVID-19 vaccine hesitancy. Early cancer stages (stages I and II) and good compliance with prior influenza vaccinations were significant factors associated with the acceptance of the COVID-19 vaccine.

Conclusions: Many patients with cancer are hesitant about COVID-19 vaccination. Well-designed problem-based educational interventions will increase compliance with COVID-19 vaccination.

Citing Articles

Predicting the hub interactome of COVID-19 and oral squamous cell carcinoma: uncovering ALDH-mediated Wnt/β-catenin pathway activation via salivary inflammatory proteins.

Yadalam P, Arumuganainar D, Natarajan P, Ardila C Sci Rep. 2025; 15(1):4068.

PMID: 39901050 PMC: 11790915. DOI: 10.1038/s41598-025-88819-2.

COVID-19 vaccination patterns among oral cancer patients: A comprehensive analysis in a medical center in Taiwan.

Cheng C, Liu H, Lee L J Dent Sci. 2025; 20(1):335-341.

PMID: 39873075 PMC: 11762919. DOI: 10.1016/j.jds.2024.06.020.

COVID-19 Vaccine Hesitancy Among Pediatric Oncology and Bone Marrow Transplant Patients.

ONeill S, Tran S, Constantinescu C, Truong T Vaccines (Basel). 2025; 12(12.

PMID: 39772068 PMC: 11680243. DOI: 10.3390/vaccines12121407.

Is COVID-19 Vaccination Beneficial for Tumor Patients: A Cross-Sectional Investigation in China.

Wang S, Zhu Y, Chen T, Lin C, Chen L, Niu Y Immun Inflamm Dis. 2024; 12(11):e70069.

PMID: 39601455 PMC: 11600451. DOI: 10.1002/iid3.70069.

Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12-2023.4 wave of the COVID-19 pandemic.

Dai R, Peng W, Xu N, Qin P, Ding L, Hua Q Front Immunol. 2024; 15:1476186.

PMID: 39569188 PMC: 11576375. DOI: 10.3389/fimmu.2024.1476186.

References

Koelemay M, VerMeulen H . Quick Guide to Systematic Reviews and Meta-analysis. Eur J Vasc Endovasc Surg. 2015; 51(2):309. DOI: 10.1016/j.ejvs.2015.11.010. View

Barriere J, Gal J, Hoch B, Cassuto O, Leysalle A, Chamorey E . Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Ann Oncol. 2021; 32(5):673-674. PMC: 7846886. DOI: 10.1016/j.annonc.2021.01.066. View

Moujaess E, Bou Zeid N, Samaha R, Sawan J, Kourie H, Labaki C . Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey. Future Oncol. 2021; 17(31):4071-4079. PMC: 8328088. DOI: 10.2217/fon-2021-0265. View

Gheorghe A, Negru S, Nitipir C, Mazilu L, Marinca M, Gafton B . Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey. ESMO Open. 2021; 6(1):100027. PMC: 7808020. DOI: 10.1016/j.esmoop.2020.100027. View

Heudel P, Favier B, Assaad S, Zrounba P, Blay J . Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients. Ann Oncol. 2021; 32(11):1443-1444. PMC: 8321960. DOI: 10.1016/j.annonc.2021.07.012. View

Batteux E, Mills F, Jones L, Symons C, Weston D . The Effectiveness of Interventions for Increasing COVID-19 Vaccine Uptake: A Systematic Review. Vaccines (Basel). 2022; 10(3). PMC: 8949230. DOI: 10.3390/vaccines10030386. View

Chan W, Ho Y, Wong C, Choi H, Lam K, Yuen K . Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate. Vaccines (Basel). 2021; 9(7). PMC: 8310340. DOI: 10.3390/vaccines9070792. View

He Y, Ding Y, Cao B, Huang Y, Wang X . COVID-19 vaccine development from the perspective of cancer patients. Hum Vaccin Immunother. 2021; 17(10):3281-3287. PMC: 8437497. DOI: 10.1080/21645515.2021.1943988. View

Aw J, Seng J, Seah S, Low L . COVID-19 Vaccine Hesitancy-A Scoping Review of Literature in High-Income Countries. Vaccines (Basel). 2021; 9(8). PMC: 8402587. DOI: 10.3390/vaccines9080900. View

10.

Makhlouf S, Pini S, Ahmed S, Bennett M . Managing Pain in People with Cancer-a Systematic Review of the Attitudes and Knowledge of Professionals, Patients, Caregivers and Public. J Cancer Educ. 2019; 35(2):214-240. PMC: 7076060. DOI: 10.1007/s13187-019-01548-9. View

11.

Villarreal-Garza C, Vaca-Cartagena B, Becerril-Gaitan A, Ferrigno A, Mesa-Chavez F, Platas A . Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer. JAMA Oncol. 2021; 7(8):1242-1244. PMC: 8193544. DOI: 10.1001/jamaoncol.2021.1962. View

12.

de Sousa M, Caramujo C, Julio N, Magalhaes J, Basto R, Fraga T . Acceptance of SARS-CoV-2 vaccination among cancer patients in Portugal: attitudes and associated factors. Support Care Cancer. 2022; 30(5):4565-4570. PMC: 8815020. DOI: 10.1007/s00520-022-06886-x. View

13.

Heyne S, Esser P, Werner A, Lehmann-Laue A, Mehnert-Theuerkauf A . Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: a cross-sectional survey. J Cancer Res Clin Oncol. 2022; 148(6):1363-1374. PMC: 8881553. DOI: 10.1007/s00432-022-03961-y. View

14.

Mejri N, Berrazega Y, Ouertani E, Rachdi H, Bohli M, Kochbati L . Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients. Support Care Cancer. 2021; 30(1):289-293. PMC: 8286987. DOI: 10.1007/s00520-021-06419-y. View

15.

Hong J, Xu X, Yang J, Zheng J, Dai S, Zhou J . Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey. J Integr Med. 2021; 20(1):34-44. PMC: 8559872. DOI: 10.1016/j.joim.2021.10.004. View

16.

Roupa Z, Noula M, Nikitara M, Ghobrial S, Latzourakis E, Polychronis G . Acceptance of coronavirus disease 2019 vaccination by cancer patients in Cyprus: A cross-sectional study. J Oncol Pharm Pract. 2021; 28(8):1696-1703. PMC: 9623334. DOI: 10.1177/10781552211039489. View

17.

Paez A . Gray literature: An important resource in systematic reviews. J Evid Based Med. 2017; 10(3):233-240. DOI: 10.1111/jebm.12266. View

18.

Boness C, Nelson M, Douaihy A . Motivational Interviewing Strategies for Addressing COVID-19 Vaccine Hesitancy. J Am Board Fam Med. 2022; 35(2):420-426. DOI: 10.3122/jabfm.2022.02.210327. View

19.

Waters A, Kepka D, Ramsay J, Mann K, Vaca Lopez P, Anderson J . COVID-19 Vaccine Hesitancy Among Adolescent and Young Adult Cancer Survivors. JNCI Cancer Spectr. 2021; 5(3):Pkab049. PMC: 8239168. DOI: 10.1093/jncics/pkab049. View

20.

Matovina Brko G, Popovic M, Jovic M, Radic J, Bodlovic Kladar M, Nikolic I . COVID-19 vaccines and cancer patients: acceptance, attitudes and safety. J BUON. 2021; 26(5):2183-2190. View